152 related articles for article (PubMed ID: 38687756)
1. Work participation, social roles, and empowerment of Q-fever fatigue syndrome patients ≥10 years after infection.
Brus IM; Teng ASJ; Heemskerk SCM; Polinder S; Tieleman P; Hartman E; Dollekens B; Haagsma JA; Spronk I
PLoS One; 2024; 19(4):e0302573. PubMed ID: 38687756
[TBL] [Abstract][Full Text] [Related]
2. Impact of Q-fever fatigue syndrome on patients' work status.
Reukers DFM; van Loenhout JAF; Roof I; Senden TF; Keijmel SP; Bleeker-Rovers CP; van Jaarsveld CHM; Hautvast JLA; van der Velden K
Occup Med (Lond); 2020 Dec; 70(8):578-585. PubMed ID: 33073289
[TBL] [Abstract][Full Text] [Related]
3. Long-term impact of a Q-fever outbreak: An evaluation of health symptoms, health-related quality of life, participation and health care satisfaction after ten years.
Bronner MB; Haagsma JA; Dontje ML; Barmentloo L; Kouwenberg RMCEJ; Olde Loohuis AGM; de Groot A; Erasmus V; Polinder S
J Psychosom Res; 2020 Dec; 139():110258. PubMed ID: 33069049
[TBL] [Abstract][Full Text] [Related]
4. Explaining the long-term impact of chronic Q fever and Q fever fatigue syndrome on psychosocial functioning: A comparison with diabetes and the general population.
Reukers DFM; van Jaarsveld CHM; Knoop H; Bleeker-Rovers CP; Akkermans R; de Grauw W; van der Velden K; van Loenhout JAF; Hautvast JLA
J Psychosom Res; 2019 Jun; 121():37-45. PubMed ID: 31006533
[TBL] [Abstract][Full Text] [Related]
5. Impact of Q-fever on physical and psychosocial functioning until 8 years after Coxiella burnetii infection: An integrative data analysis.
Reukers DFM; van Jaarsveld CHM; Akkermans RP; Keijmel SP; Morroy G; van Dam ASG; Wever PC; Wielders CCH; van der Velden K; van Loenhout JAF; Hautvast JLA
PLoS One; 2022; 17(2):e0263239. PubMed ID: 35108330
[TBL] [Abstract][Full Text] [Related]
6. Altered interferon-γ response in patients with Q-fever fatigue syndrome.
Keijmel SP; Raijmakers RP; Bleeker-Rovers CP; van der Meer JW; Netea MG; Schoffelen T; van Deuren M
J Infect; 2016 Apr; 72(4):478-85. PubMed ID: 26820634
[TBL] [Abstract][Full Text] [Related]
7. A possible role for mitochondrial-derived peptides humanin and MOTS-c in patients with Q fever fatigue syndrome and chronic fatigue syndrome.
Raijmakers RPH; Jansen AFM; Keijmel SP; Ter Horst R; Roerink ME; Novakovic B; Joosten LAB; van der Meer JWM; Netea MG; Bleeker-Rovers CP
J Transl Med; 2019 May; 17(1):157. PubMed ID: 31088495
[TBL] [Abstract][Full Text] [Related]
8. The Qure study: Q fever fatigue syndrome--response to treatment; a randomized placebo-controlled trial.
Keijmel SP; Delsing CE; Sprong T; Bleijenberg G; van der Meer JW; Knoop H; Bleeker-Rovers CP
BMC Infect Dis; 2013 Mar; 13():157. PubMed ID: 23536997
[TBL] [Abstract][Full Text] [Related]
9. [Persistent fatigue following Q fever].
Keijmel SP; Morroy G; Delsing CE; Bleijenberg G; Bleeker-Rovers CP; Timen A
Ned Tijdschr Geneeskd; 2012; 156(48):A5258. PubMed ID: 23191971
[TBL] [Abstract][Full Text] [Related]
10. A comparison of patients with Q fever fatigue syndrome and patients with chronic fatigue syndrome with a focus on inflammatory markers and possible fatigue perpetuating cognitions and behaviour.
Keijmel SP; Saxe J; van der Meer JW; Nikolaus S; Netea MG; Bleijenberg G; Bleeker-Rovers CP; Knoop H
J Psychosom Res; 2015 Oct; 79(4):295-302. PubMed ID: 26272528
[TBL] [Abstract][Full Text] [Related]
11. Long-term health outcomes of Q-fever fatigue syndrome patients.
Spronk I; Brus IM; de Groot A; Tieleman P; Olde Loohuis AGM; Haagsma JA; Polinder S
Epidemiol Infect; 2023 Sep; 151():e179. PubMed ID: 37724460
[TBL] [Abstract][Full Text] [Related]
12. Cytokine profiles in patients with Q fever fatigue syndrome.
Raijmakers RPH; Koeken VACM; Jansen AFM; Keijmel SP; Roerink ME; Joosten LAB; Netea MG; van der Meer JWM; Bleeker-Rovers CP
J Infect; 2019 May; 78(5):349-357. PubMed ID: 30684502
[TBL] [Abstract][Full Text] [Related]
13. Objective cognitive performance and subjective complaints in patients with chronic Q fever or Q fever fatigue syndrome.
Reukers DFM; Aaronson J; van Loenhout JAF; Meyering B; van der Velden K; Hautvast JLA; van Jaarsveld CHM; Kessels RPC
BMC Infect Dis; 2020 Jun; 20(1):397. PubMed ID: 32503444
[TBL] [Abstract][Full Text] [Related]
14. Interferon-γ and CXCL10 responses related to complaints in patients with Q fever fatigue syndrome.
Raijmakers RPH; Jansen AFM; Keijmel SP; Schoffelen T; Scholzen A; van der Meer JWM; Joosten LAB; Netea MG; van Deuren M; Bleeker-Rovers CP
Eur J Clin Microbiol Infect Dis; 2018 Jul; 37(7):1385-1391. PubMed ID: 29804281
[TBL] [Abstract][Full Text] [Related]
15. Fatigue following Acute Q-Fever: A Systematic Literature Review.
Morroy G; Keijmel SP; Delsing CE; Bleijenberg G; Langendam M; Timen A; Bleeker-Rovers CP
PLoS One; 2016; 11(5):e0155884. PubMed ID: 27223465
[TBL] [Abstract][Full Text] [Related]
16. Multi-omics examination of Q fever fatigue syndrome identifies similarities with chronic fatigue syndrome.
Raijmakers RPH; Roerink ME; Jansen AFM; Keijmel SP; Gacesa R; Li Y; Joosten LAB; van der Meer JWM; Netea MG; Bleeker-Rovers CP; Xu CJ
J Transl Med; 2020 Nov; 18(1):448. PubMed ID: 33243243
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of Long-term Doxycycline Treatment and Cognitive-Behavioral Therapy on Fatigue Severity in Patients with Q Fever Fatigue Syndrome (Qure Study): A Randomized Controlled Trial.
Keijmel SP; Delsing CE; Bleijenberg G; van der Meer JWM; Donders RT; Leclercq M; Kampschreur LM; van den Berg M; Sprong T; Nabuurs-Franssen MH; Knoop H; Bleeker-Rovers CP
Clin Infect Dis; 2017 Apr; 64(8):998-1005. PubMed ID: 28329131
[TBL] [Abstract][Full Text] [Related]
18. Identifying disrupted biological factors and patient-tailored interventions for chronic fatigue in adolescents and young adults with Q-Fever Fatigue Syndrome, Chronic Fatigue Syndrome and Juvenile Idiopathic Arthritis (QFS-study): study protocol for a randomized controlled trial with single-subject experimental case series design.
Vroegindeweij A; Swart JF; Houtveen J; Eijkelkamp N; van de Putte EM; Wulffraat NM; Nijhof SL
Trials; 2022 Aug; 23(1):683. PubMed ID: 35986408
[TBL] [Abstract][Full Text] [Related]
19. A possible link between recurrent upper respiratory tract infections and lower cytokine production in patients with Q fever fatigue syndrome.
Raijmakers RPH; Jansen AFM; Keijmel SP; van der Meer JWM; Joosten LAB; Netea MG; Bleeker-Rovers CP
Eur J Immunol; 2019 Jul; 49(7):1015-1022. PubMed ID: 31001808
[TBL] [Abstract][Full Text] [Related]
20. Cytokine dysregulation in the post-Q-fever fatigue syndrome.
Penttila IA; Harris RJ; Storm P; Haynes D; Worswick DA; Marmion BP
QJM; 1998 Aug; 91(8):549-60. PubMed ID: 9893758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
